Endo Pharmaceuticals

Pharma

Jury awards $885M in Takeda pay-for-delay antitrust case

Takeda plans to appeal after a jury found it liable in a landmark pay-for-delay antitrust case and ordered the Japanese drugmaker to pay $885 million.

Kevin Dunleavy May 19, 2026 8:39am

Knight swoops in to pick up Endo’s Paladin Pharma for up to $99M

Mar 11, 2025 11:32am

Astellas, Endo issue separate US drug recalls

Jan 3, 2025 9:20am

Endo recalls 1 lot of panic disorder drug due to labeling issue

Jul 17, 2024 11:32am

Par recalls batch of Remodulin generic over particulate concerns

Mar 13, 2024 8:15am